Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres:
2021
Background:Oral cladribine has been approved for the treatment of relapsing multiple sclerosis (MS) yet real-world evidence regarding its effectiveness and safety remains scarce.Objective:To evalua...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
22
References
2
Citations
NaN
KQI